The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and that in all the studies that we see the people for whom LDL is the greatest risk factor are people in which they have other markers of endothelial dysfunction people with metabolic syndrome people with chronic inflammation and we can see this reflected and things like HDL to triglyceride ratio fasting insulin inflammatory markers glucose tolerance
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.